COR
Cencora, Inc.NYSEHealthcare$324.80+2.25%OpenMarket Cap: $63.18B
As of 2026-04-06
Valuation
P/E (TTM)
38.88
PEG
2.37
P/B
33.06
P/S
0.19
EV/EBITDA
18.16
DCF Value
$602.82
FCF Yield
5.7%
Div Yield
0.7%
Margins & Returns
Gross Margin
3.3%
Operating Margin
1.2%
Net Margin
0.5%
ROE
101.4%
ROA
2.7%
ROIC
13.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $85.93B | 3.3% | $1.02B | $559.6M | $2.87 | $0.60 |
| Q4 2025 | $83.73B | 3.1% | $854.6M | $-339.7M | $-1.75 | $0.55 |
| FY 2025 | $321.33B | 3.2% | $3.65B | $1.55B | $7.96 | $2.20 |
| Q3 2025 | $80.66B | 3.3% | $985.5M | $687.4M | $3.52 | $0.55 |
| Q2 2025 | $75.45B | 3.5% | $1.02B | $717.9M | $3.68 | $0.55 |
| Q1 2025 | $81.49B | 2.8% | $791.8M | $488.6M | $2.50 | $0.55 |
| Q4 2024 | $79.05B | 2.7% | $672.9M | $3.4M | $0.02 | $0.51 |
| FY 2024 | $293.96B | 3.0% | $3.04B | $1.51B | $7.53 | $2.04 |
| Q3 2024 | $74.24B | 2.8% | $703.4M | $483.5M | $2.42 | $0.51 |
| Q2 2024 | $68.41B | 3.3% | $868.8M | $420.8M | $2.09 | $0.51 |
| Q1 2024 | $72.25B | 3.0% | $751.2M | $601.5M | $2.98 | $0.51 |
| Q4 2023 | $68.92B | 2.8% | $512.8M | $350.6M | $1.72 | $0.49 |